Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Status:
Completed
Trial end date:
2021-09-02
Target enrollment:
Participant gender:
Summary
QWO™ (CCH-aaes) is indicated for the treatment of moderate to severe cellulite in the
buttocks of adult women. QWO™ (CCH-aaes)-related post-injection bruising was the most common
adverse reaction; generally, resolving within 21 days. Since bruising may be bothersome to
patients, this study will investigate treatments that may mitigate bruising after QWO™
(CCH-aaes) treatment of cellulite in the buttocks.
Phase:
Phase 4
Details
Lead Sponsor:
Endo Pharmaceuticals
Collaborators:
Brian Biesman, MD, PLLC DeNova Research Investigate MD, LLC Laser & Skin Surgery Medical Group, Inc. Mathew Avram, MD Plastic Surgical Associates of Fort Collins, P.C. The Wall Center for Plastic Surgery UCSD Dermatology